Notification regarding unquoted securities - EMD

In our recent announcement on March 5, 2025, Emyria Limited disclosed the issuance of unlisted options under an employee incentive scheme. These options, exercisable at $0.064 each and expiring on March 4, 2029, total 5,650,000, along with another set of options exercisable at $0.051 each and expiring on March 4, 2028, totaling 5,000,000. The entity's ASX issuer code is EMD.

This issuance is part of our commitment to incentivizing and rewarding our staff under the Employee Securities Incentive Plan approved at the 2022 Annual General Meeting. The options issued will not be quoted on ASX. Following this notification, our issued capital includes various securities, with the total number of ordinary fully paid securities on issue standing at 460,589,396.

We invite investors to seek clarification or further details on this important development, which reflects our ongoing efforts to drive growth and value for our stakeholders. Your trust and support are paramount to our mission of advancing patient outcomes in neuroscience and mental health. Please feel free to reach out with any questions or inquiries regarding this announcement.